Metoprolol Succinate Tablet, Extended Release
Product Images NDC 82804-014

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 82804-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Figure001)

A forest plot chart showing the results for subgroups in the MERIT-HE study, comparing Metoprolol Succinate Extended-Release Tablets versus placebo. The chart displays relative risk and 95% confidence intervals across various subgroups for three endpoints: Total Mortality, Total Mortality or All-Cause Hospitalization, and Total Mortality or Hospitalization for Heart Failure, each with indicators favoring either Metoprolol Succinate or placebo.*

FDA Label Image

82804-014-90 (Image0002)

Label for Metoprolol Succinate 50 mg extended-release tablets, packaged by Proficient Rx LP. The label shows quantity as 90 tablets. Each tablet contains 47.5 mg metoprolol succinate equivalent to 50 mg metoprolol tartrate, USP. It includes storage instructions and manufacturer information for Visum Pharmaceutical Co., Ltd, Haikou, China. Several smaller identical labels with product details and barcodes are also attached.*

FDA Label Image

Structure (Structure001)

Chemical structure diagram of Metoprolol Succinate, showing the molecular components of the active ingredient and its succinate moiety. The structure includes phenyl and ether groups, with a detailed depiction of functional groups relevant to Metoprolol Succinate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.